bradley mcgregor, md, considers the optimal approach to treating newly diagnosed rcc patients
Published 5 years ago • 46 plays • Length 2:09
Download video MP4
Download video MP3
Similar videos
-
1:18
bradley mcgregor, md, considers strategies for treating 2nd line rcc patients
-
1:01
bradley mcgregor, md, describes if biomarkers help guide treatment in advanced renal cell carcinoma
-
2:06
dr. mcgregor on whether patients need frontline combinations in rcc
-
1:13
bradley mcgregor, md, on mrcc patients whose cancer returns and were previously treated with i-o
-
0:56
dr mcgregor on the future implications of ongoing research in rcc
-
1:19
bradley mcgregor, md, on impressions of the oral inhibitor study in renal cell carcinoma patients
-
9:03
applications of flow cytometry
-
3:26
understanding your kidney cancer diagnosis
-
3:41
a physician faces stage iv #kidneycancer: his advice for you
-
6:57
newly diagnosed metastatic rcc: frontline therapy
-
1:49
bradley mcgregor, md, discusses checkmate-214 investigating nivolumab ipilimumab in rcc patients
-
1:49
dr. mcgregor on immunotherapy combinations in kidney cancer
-
1:03
dr. mcgregor on the evolving treatment landscape of rcc
-
1:29
bradley mcgregor, md, on combo ipilimumab nivolumab in variant histologies of bladder cancer
-
1:47
dr. mcgregor on choosing a combination therapy regimen in advanced rcc
-
1:32
bradley mcgregor, md, shares presented data investigating atezolizumab and cabozantinib in mcrpc
-
0:53
dr. mcgregor on challenges facing frontline treatments for rcc
-
1:34
dr mcgregor on the clinical implications of the dad-io trial in urothelial carcinoma
-
1:16
bradley mcgregor, md, on the data regarding enfortumab in post-platinum i-o bladder cancer
-
1:47
dr. choueiri discusses avelumab/axitinib data in rcc
-
1:02
an expert looks to the future of metastatic kidney cancer treatment
-
1:56
nivolumab and ipilimumab for advanced bcvh
Clip.africa.com - Privacy-policy